[{"Assets_0_Q2_USD":"453957000.0","CIK":"1628171","CommonStockSharesIssued_0_Q2_shares":"59015868.0","CommonStockSharesOutstanding_0_Q2_shares":"59015868.0","Country":"United States","Industry":"Specialty Chemicals","Market":"NASDAQ","Market Cap":"1775342076.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":"-48009000.0","NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":"-27215000.0","NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":"-48953000.0","NetIncomeLoss_1_Q2_USD":"-27215000.0","NetIncomeLoss_2_Q2_USD":"-46734000.0","OfficialName":"Revolution Medicines Inc. Common Stock","ProfitLoss_2_Q2_USD":"-46734000.0","RevenuesConverted_1_Q2_USD":"10025000.0","RevenuesConverted_2_Q2_USD":"21571000.0","SP500":null,"Sector":"Consumer Durables","StockholdersEquity_0_Q2_USD":"360498000.0","Ticker":"RVMD","WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":"58752494.0","WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":"44025372.0","filed":"20200810","footnote":null,"form":"10-Q","fp":"Q2","fy":"2020.0","name":"REVOLUTION MEDICINES, INC.","period":"20200630","qtrs":"1","uom":"USD"}]